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Following skeletal muscle injury, muscle stem cells
(satellite cells) are activated, proliferate, and differen-
tiate to form myofibers. We show that mRNA-decay
protein AUF1 regulates satellite cell function through
targeted degradation of specific mRNAs containing
30 AU-rich elements (AREs). auf1/ mice undergo
accelerated skeletal muscle wasting with age and
impaired skeletal muscle repair following injury. Sat-
ellite cell mRNA analysis and regeneration studies
demonstrate that auf1/ satellite cell self-renewal
is impaired due to increased stability and overex-
pression of ARE-mRNAs, including cell-autonomous
overexpression of matrix metalloprotease MMP9.
Secreted MMP9 degrades the skeletal muscle ma-
trix, preventing satellite-cell-mediated regeneration
and return to quiescence. Blocking MMP9 activity
in auf1/ mice restores skeletal muscle repair and
maintenance of the satellite cell population. Control
of ARE-mRNA decay by AUF1 represents a mecha-
nism for adult stem cell regulation and is implicated
in human skeletal muscle wasting diseases.
INTRODUCTION
Many key regulatory mRNAs are controlled through post-tran-
scriptional mechanisms; typically, the targeted destabilization
of the mRNA, its selective translation, or both (Moore et al.,
2014). The regulated stability of mRNAs generally comprises
those that must respond quickly in abundance to changing stim-
uli. In fact, almost half of the changes in physiologically rapid
inducible gene expression occur at the level of mRNA stability
(Cheadle et al., 2005). Many physiologically potent proteins are
encoded by short-lived mRNAs with half-lives of minutes, in
which mRNA destabilization is conferred by AU-rich elements
(AREs) in the 30 UTR. A common ARE motif consists of the
sequence AUUUA, typically repeated multiple times in the 30
UTR, often contiguously (Moore et al., 2014). The ARE is purelyCell
This is an open access article under the CC BY-Na cis-acting element that serves as a binding site for regulatory
proteins known as AU-rich binding proteins (AUBPs), which
bind the ARE with high affinity and control mRNA stability or
translation. Several AUBPs have been studied to date, and all
act by recruiting mRNA-decay, mRNA-stabilizing, or transla-
tion-arrest proteins (Grataco´s and Brewer, 2010). AUBPs also
have different and overlapping target ARE-mRNAs (Garneau
et al., 2007; Kim et al., 2009). ARE-mRNAs are thought to
encodemore than 5% of the protein-expressed genome (Gruber
et al., 2011).
AU-rich binding factor 1 (AUF1; also known as HNRNPD)
binds certain ARE-mRNAs to promote their rapid degradation
through association with trans-acting RNA binding proteins
(Moore et al., 2014). AUF1 primarily functions as an ARE-
mRNA decay factor (Moore et al., 2014; von Roretz et al.,
2011). AUF1 consists of four related protein isoforms named
for their molecular weights (p37, p40, p42, and p45), derived
by differential exon splicing of a common pre-mRNA (Wagner
et al., 1998). While not fully understood, the different isoforms
target ARE-mRNAs for decay and interact in a variety of homo-
and hetero-complexes (Moore et al., 2014). AUF1 isoforms
have also been implicated in transcriptional control of several
genes based on their multimer formation and cellular distribution
(Pont et al., 2012; Zucconi et al., 2010), as AUF1 isoforms can
shuttle between the nucleus and cytoplasm at different effi-
ciencies (He and Schneider, 2006; Sarkar et al., 2003a, 2003b).
We previously developed an auf1/ (auf1 knockout; KO)
mouse to better understand its physiological roles (Lu et al.,
2006). We report that auf1/mice undergo accelerated skeletal
muscle wasting as adults. Skeletal muscle maintenance and
regeneration in adults requires activation and differentiation of
normally quiescent satellite cells, a skeletal-muscle-specific
stem cell population (Lipton and Schultz, 1979). Satellite cells
reside under the basal lamina, adjacent to myofibers, the bun-
dles of muscle fibers that provide muscle mass and strength.
Following muscle injury, satellite cells respond through rapid
proliferation and differentiation, recapitulating the process of
myogenesis (the formation of muscle tissue), including fusion,
to form myofibers (Brack, 2014; G€unther et al., 2013; Kudrya-
shova et al., 2012; Lepper et al., 2009). Satellite cells must also
self-renew and quiesce to prevent their depletion. Satellite cells,Reports 16, 1379–1390, August 2, 2016 ª 2016 The Authors. 1379
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. auf1/ Mice Show Accelerated
Muscle Wasting
(A) Visual comparison of skeletal muscle mass
between 4-month-old WT and KO mice.
(B) DEXA measurement of lean muscle mass
normalized to total mass in young (3–5 months
old), mid-range (6–8 months old), and old
(9–12 months old) WT (black) and KO (gray) mice.
Five mice per genotype per age group were tested
in triplicate. *p < 0.05; **p < 0.005, unpaired t test.
(C) Results of limb and pectoral strength test by
inverted cage flip lasting up to 60 s in young
(3–5 months old), mid-range (6–8 months old), and
old (9–12 months old) WT (black) and KO (gray)
mice. Five mice per genotype per age group were
tested in triplicate. *p < 0.05, unpaired t test.
(D) Immunofluorescence analysis of skeletal
muscle laminin (AF488, green) and nuclei (DAPI,
blue) in 4- and 8-month-old mice. Representative
centralized nuclei are denoted by arrowheads (< ).
TA muscles were frozen in OCT compound, five
images from three sections were analyzed per
mouse, and three mice were studied per genotype
(scale bars, 50 mm).
(E) Quantification of centralized nuclei in 4-month-
old and 8-month-old WT (black) and KO
(patterned) mice. **p < 0.005, by two-way ANOVA.
Error bars indicate SD.therefore, divide asymmetrically, enabling a small number of
stem cells to return to quiescence, mediated partly through inter-
action with the satellite cell niche (Kuang et al., 2007). The satel-
lite cell niche is loosely defined as the intact laminin-basement
membrane structure that provides poorly characterized extrinsic
factors crucial for their maintenance (Bernet et al., 2014; Carlson
and Conboy, 2007; Collins et al., 2005; Kuang et al., 2007; Mon-
tarras et al., 2005; Zammit et al., 2004).
Skeletal muscle regeneration is impaired in age-related dis-
eases such as sarcopenia, which is marked by reduced muscle
regenerative capacity with aging, partly due to a reduction in sat-
ellite cells (Bernet et al., 2014; Carlson and Conboy, 2007; Shefer
et al., 2006). Loss of the satellite cell populationmay result from a
release of cell-cycle inhibition (Sousa-Victor et al., 2014) and/or
loss of the niche (Gopinath and Rando, 2008). These events
are also common to certain adult late-onset myopathies,
including limb girdle muscular dystrophy (LGMD). LGMD is a
heterogeneous family of diseases characterized clinically by
adult-onset rapid loss of skeletal muscle in the pelvic, scapular,
shoulder, and limb regions of the body (Brack, 2014; G€unther
et al., 2013; Kudryashova et al., 2012; Lepper et al., 2009).
Therefore, we sought to elucidate the role of AUF1 in skeletal
muscle maintenance with age. Here, we show that AUF1-medi-
ated control of satellite cell ARE-mRNA stability is a key regulator1380 Cell Reports 16, 1379–1390, August 2, 2016of muscle stem cell fate and regenerative
capacity in mice. auf1/ satellite cells
show increased expression of key regen-
erative ARE-mRNAs, including mmp9,
that regulate the integrity of the muscle
stem cell niche. By altering the niche,
impaired auf1/ satellite cell self-
renewal leads to impaired muscle regeneration and satellite
cell depletion and, ultimately, promotes late-onset myopathy.
RESULTS
auf1/ Mice Increasingly Lose Muscle Mass and
Strength with Age
A severe loss in skeletal muscle mass was apparent in auf1/
skeletal muscle relative to wild-type (WT) littermates by 6months
of age, as evident in anatomical images (Figure 1A). The progres-
sive loss of skeletal muscle mass in auf1/mice was quantified
by dual-energy X-ray absorptiometry (DEXA), which measures
body composition, including skeletal muscle mass (Harada,
2013; Marinangeli and Kassis, 2013). DEXA analysis showed a
reduction in auf1/ mouse skeletal muscle mass of 50% by
6 months of age and 85% by 9 months (Figure 1B). Thus, there
is a severe, progressive loss of skeletal muscle mass associated
with age in auf1/ mice. Therefore, we determined whether the
loss of muscle mass corresponds to a loss of muscle strength as
well, using two traditional approaches. The inverted cage flip
quantifies the amount of time a mouse can hold on to the bottom
of a cage. This is a measure of both limb and pectoral strength.
The grip strength test quantifies forelimb strength in countering
an opposite pull. The age-related reduction in skeletal muscle
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Figure 2. AUF1 Is Expressed in Activated
Satellite Cells
(A) Immunofluorescence analysis for the expres-
sion of laminin (AF488, green), PAX7 (AF 555, red),
AUF1 (AF647, white), and nuclei (DAPI, blue) in TA
muscle, either uninjured (UI) or 7-days post-injury,
in 4-month-oldWTmice. TAmuscle was injured by
BaCl2 injection. TA muscles were frozen in OCT
compound, and five images from three sections
were analyzed per mouse (scale bars, 50 mm).
DAPI + 2nd is a background control; sections were
stained with DAPI and secondary antibody only.
(B) Immunofluorescence analysis for expression of
AUF1 (AF488, green), MyoD (AF555, red), and
nuclei (DAPI, blue) in myofibers isolated from WT
skeletal muscle from 4-month-old mice. Ten fibers
were analyzed per mouse, and three mice were
studied (scale bars, 50 mm).mass corresponded to a 92% loss in whole-body skeletal mus-
cle strength, measured by the inverted cage flip test (Figure 1C).
The significant loss of limb muscle strength was independently
validated by the grip strength test (Figure S1).
Histologically, young auf1 KO mice initially develop normal
skeletal muscle, shown by laminin staining of tibialis anterior
(TA) muscle fibers at 4 months of age, indistinguishable from
WT animals (Figure 1D). At this time, laminin completely outlines
rounded skeletal muscle fibers with virtually all peripheral myo-
nuclei (Figure 1E), a key measure of normal muscle development
(Wicklund and Kissel, 2014). However, auf1 KO mice develop a
drastic myopathy phenotype by 8 months of age, particularly
showing signs of muscle wasting (Figure 1D). This is visually
apparent in deficient and disrupted laminin staining indicative
of a loss of muscle integrity, including skeletal muscle fibers
that are incomplete with pronounced degradation. Notably, the
8-month-old auf1 KO phenotype includes a >5-fold increase in
centrally located nuclei within muscle fibers (Figure 1E), indica-
tive of ongoing satellite cell regeneration efforts and a pheno-
typic hallmark of myopathic disease (Wicklund and Kissel, 2014).
AUF1 Shows Exclusive Expression in Activated Satellite
Cells within the Muscle
Studies have shown that AUF1 is expressed at extremely low or
negligible levels in skeletal muscle fibers (Lu and Schneider,
2004) (Figures 2A and 2B). Therefore, we screened for AUF1
expression using immunofluorescence specifically in the quies-
cent and activated satellite cell populations in vivo following
injury and in vitro on isolated skeletal muscle fibers. Quiescent
satellite cells are identified by the expression of PAX7 and Syn-
decan-4 (Sdc4), while activated satellite cells additionally gainCell Reexpression of myogenic regulatory fac-
tors (MRFs) such as MyoD (Cornelison
and Wold, 1997; Seale and Rudnicki,
2000). There was little or no detectable
AUF1 expression in quiescent satellite
cells prior to muscle injury. However,
AUF1 was co-expressed in 25% of the
activated PAX7+ satellite cells 7 dayspost-injury (Figures 2A and S2). In skeletal muscle, both unin-
jured and at 7 days post-injury, AUF1 expression was not
observed in the skeletal muscle fibers (Figure 2A). AUF1 is, there-
fore, specifically expressed in a subset of activated satellite
cells.
To further validate restriction of AUF1 expression to activated
satellite cells, skeletal muscle fibers were isolated, cultured, and
screened for AUF1 co-expression withMyoD, an early time point
MRF. The isolation of muscle fibers activates associated satellite
cells that attempt to repair the sensed ‘‘wound’’ by differentia-
tion. At 72 hr of culture, AUF1 was strongly co-expressed in
>50% of the MyoD+ satellite cells (Figures 2B and S2). Notably,
AUF1 distribution was found to be nuclear and cytoplasmic,
indicative of increased cytoplasmic ARE-mRNA decay function.
AUF1 has been shown to shuttle between the nucleus and the
cytoplasm (the cytoplasm being where it promotes ARE-mRNA
decay). At steady state, AUF1 is primarily nuclear, with export
to the cytoplasm occurring as a result of specific mRNA associ-
ation for decay (Moore et al., 2014; Sarkar et al., 2003a; Suzuki
et al., 2005; Yoon et al., 2015; He and Schneider, 2006). Collec-
tively, these data demonstrate that AUF1 is only expressed in
activated satellite cells in skeletal muscle and not in muscle
fibers.
Independent confirmation of the AUF1 temporal expression
profile was obtained using the murine myoblast C2C12 cell
line. C2C12 cells can mimic the post-activated satellite cell state
initiating at the progenitor myoblast level (Ho et al., 2015; Silva
et al., 2015). The three largest AUF1 isoforms (p40, p42, and
p45) are expressed in the proliferating myoblast (Figure S3)
and significantly increased through the early stages of myoblast
differentiation, similar to the differentiation of skeletal muscleports 16, 1379–1390, August 2, 2016 1381
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Figure 3. auf1/ Satellite Cells Are Unable
to Self-Renew Once Activated
(A) Immunofluorescence analysis for expression of
laminin (AF-488, green), PAX7 expression (AF555,
red), and nuclei (DAPI, blue) in skeletal muscle, at 7
or 15 days post-injury, in 4-month-old WT and KO
mice. TAmuscle was injured by BaCl2 injection. TA
muscles were frozen in OCT compound; five im-
ages from three sections were analyzed per
mouse (scale bars, 50 mm). DAPI + 2nd is a control;
sections were stained with DAPI and secondary
antibody only.
(B) Quantification of fiber size by minimum Feret’s
diameter determined by ImageJ64 at 15 days
post-injury in WT (black) and KO (gray) mice. Bars
denoting significance represent the range in which
minimum Feret’s diameter is significantly different
between WT and auf1 KO TA muscle. *p < 0.05;
**p < 0.005, unpaired t test.
(C) Quantification of PAX7 expression in WT and
KO mice in skeletal muscle, uninjured (black) or at
7 days post-injury (patterned)or 15 days post-
injury (gray). *p < 0.05; ***p < 0.0005, two-way
ANOVA.
Error bars represent SD.satellite cells in the animal. The smallest isoform (p37) is mini-
mally expressed in the fully differentiated myotubes (Figure S3).
AUF1 Regulation of ARE-mRNA Stability Controls
Satellite Cell Fate following Muscle Injury
Next, we determined whether satellite cells and their regenera-
tive capacity are functionally altered in the absence of AUF1-
mediated regulation of ARE-mRNA stability. To activate quies-
cent satellite cells and initiate the program of muscle stem cell1382 Cell Reports 16, 1379–1390, August 2, 2016differentiation, the TA muscle was injured
by injection of BaCl2 in WT and auf1 KO
mice at 4 months of age. BaCl2 causes
rapid necrosis of the injected muscle. At
this time point, as shown earlier, uninjured
skeletal muscle from auf1 KO mice is
morphologically normal (Figure 1E), and
expression of AUF1 in the quiescent sat-
ellite cell population is almost undetect-
able (Figures 2A and S4). Furthermore,
there are no changes in the number of
quiescent satellite cells present in the TA
muscle of WT and auf1 KO mice at
4 months of age (Figure 3C).
At 7 days post-injury, the TA muscle
from auf1 KO mice is unable to undergo
repair compared to that fromWT animals.
There is sparse laminin expression with
very few identifiable myofibers, indicative
of loss of muscle fiber integrity and
disruption of the satellite cell niche (Fig-
ure 3A). Evidence for loss of the satellite
cell niche includes a >5-fold reduction in
activated PAX7+ satellite cells in the auf1
KO TA muscle relative to WT (Figures 3A and 3C). At 15 days
post-injury, auf1 KO TA muscle continues to show little regener-
ation in comparison to the near-complete repair in WT mice.
Laminin staining in the auf1 KO TA muscle indicates that signifi-
cantly smaller and incomplete muscle fibers are formed (Fig-
ure 3A), quantified by determining the size (minimum Feret’s
diameter) of muscle fibers (Figure 3B). There is also a significant
depletion of the PAX7+ satellite cell population in the auf1 KO TA
muscle at this time (Figure 3A), quantified by scoring the number
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Figure 4. MMP9 Transcript Levels Are
Significantly Higher in the auf1/ Satellite
Cells
(A) Heatmap of RNA-seq analysis from sorted WT
and KO satellite cells. Three mice per genotype
were studied. Ninety-one genes were differentially
expressed in KO satellite cells, with the majority
showing increased expression (red).
(B) IPA characterization of top cellular function and
disease pathways for satellite cell ARE-mRNAs
dysregulated in the absence of AUF1 expression.
Numbers represent p 3 105.
(C) mRNA levels of AUF1 andMMP9 from cultured
C2C12 cells treated with vehicle (black) or siAUF1
(gray). Two siAUF1-targeting sequences were
used. mRNA levels were normalized to GapDH.
Each experiment was performed in triplicate. *p <
0.05; **p < 0.005, unpaired t test.
(D) Relative MMP9 mRNA decay rate in cultured
C2C12 cells treated with control (black) or siAUF1-
1 (gray). Cells were collected post-actinomycin D
(ActD) treatment, and RNA was isolated per man-
ufacturer’s instructions (TRIzol). Partial decay
curve is shown. Inset: immunoblot of AUF1 levels
post-silencing. *p < 0.001, unpaired t test.
(E) RNA immunoprecipitation of immunoglobulin G
(IgG; black) or endogenous AUF1 (gray) in C2C12
cells analyzed forMMP9 and ITGB1mRNA levels.
Experiments were performed in triplicate. ***p <
0.0005, paired t test. ITGB1 mRNA levels were not
statistically different.
Error bars represent SD.of PAX7+ cells per square millimeter (Figure 3C). AUF1 expres-
sion is, therefore, crucial for the maintenance and re-establish-
ment of both the satellite cell niche and the PAX7+ stem cell
population.
Since the primary function of AUF1 is to target ARE-mRNAs for
rapid decay, we sought to identify mRNAs with altered abun-
dance in sorted satellite cells from auf1 KO mice compared to
WT. We conducted genome-wide, satellite-cell-specific RNA
sequencing (RNA-seq) mRNA expression analysis. Satellite cells
were isolated from auf1 WT and auf1/ KO mouse whole hin-
dlimb skeletal muscle from 4- to 6-month-old animals by fluores-
cence-activated cell sorting (FACS), gating on cells positive for
satellite cell marker Sdc4 and negative for endothelial cell
markers. Ninety-one mRNAs were altered in abundance in auf1Cell ReKO, compared to WT, satellite cells, with
75% (70 mRNAs) showing >2-fold
increased abundance. Of these, 34/70,
or almost half, were mRNAs containing
30 UTRs with putative AUF1/AUBP-
binding AREs based on the ARE-motif
AUUUA, typically with at least two contig-
uous AUUUA sequences required for
AUF1 binding (Moore et al., 2014). Addi-
tionally, the majority of the ARE-mRNAs
were increased in abundance, supporting
the role of AUF1 in promoting ARE-mRNA
decay in the stem cell population (Fig-ure 4A; Table S1). Interestingly, 18 mRNAs were increased
in abundance only in auf1 KO satellite cells and were not
detectable in the WT, of which 8 contain 30 UTR multiple
AREs, including established targets of AUF1 such as IL17 (Han
et al., 2014). Other established ARE-mRNA targets of AUF1
increased in abundance in auf1 KO satellite cells, compared to
WT, and include IL10 (Sarkar et al., 2008), MMP9 (Liu et al.,
2006), GBP1, SAMSN1 (Sarkar et al., 2011), and IL1b (Pont
et al., 2012).
Next, we performed in silico analysis to identify favorable
AUF1-regulated ARE-mRNAs, focusing on mRNAs upregulated
in the auf1 KO satellite cells consistent with the primary function
of AUF1 in mediating ARE-mRNA decay. mRNAs with at least
one canonical ARE motif (AUUUA) in the 30 UTR were identifiedports 16, 1379–1390, August 2, 2016 1383
using ARESite (Table S1, identified with an asterisk). These
mRNAs were further prioritized as AUF1-preferred targets based
on established AUF1 preference for at least two ARE pentamers,
often adjacent (Grataco´s and Brewer, 2010) (Table S1, identified
with two asterisks). The prioritized gene list was subjected to in-
genuity pathway analysis (IPA) to determine functional clusters.
IPA assigns gene lists to experimentally authenticated biochem-
ical and molecular networks.
IPA revealed that upregulated mRNAs were enriched for func-
tions including cell movement, cell-to-cell signaling, cell mainte-
nance, and cell growth (Figure 4B). These pathways provide
crucial signaling for the proper activation, differentiation, and
self-renewal of stem cells in adult tissue. Notably, the upregu-
lated MMP9 transcript was identified in most of these cellular
function pathways. We characterized the importance of the
genes identified by IPA by established function in skeletal mus-
cle regeneration. Four ARE-mRNAs were identified (Table S2),
with two (IL17, MMP9) having been previously shown to bind
AUF1 in other cell types (Han et al., 2014).
MMP9 has a central importance in muscle regeneration and
wound repair (Webster et al., 2016; Gu et al., 2005; Hindi et al.,
2013; Murase and McKay, 2012) and was found in most of the
relevant pathways analyses that we conducted.MMP9 is amatrix
metallopeptidase that degrades extracellular matrix (ECM) pro-
teins, including skeletal muscle laminin, a component of the sat-
ellite cell niche (Gu et al., 2005; Hindi et al., 2013; Murase and
McKay, 2012).While controlled remodeling of the ECM is required
for skeletal muscle regeneration, excessive and/or continuous
post-wounding MMP9 activity would be predicted to deregulate
satellite cell function and impair stem-cell-regenerative capacity
through chronic degradation of the surrounding matrix (Webster
et al., 2016; Shiba et al., 2015). Accordingly, inhibition of MMP9
has been shown to improve skeletal muscle repair in certain
models of muscular dystrophy (Hindi et al., 2013; Li et al., 2009;
Shiba et al., 2015). Moreover, the extensive pathological effects
of muscle wounding in auf1 KOmice are consistent with the pre-
dicted phenotype of increased MMP activity.
Importantly, the source of MMP9 expression during muscle
wound repair and its pathological relevance when overex-
pressed have not been studied. Therefore, we first confirmed
that changes in MMP9 and other mRNAs identified by
genome-wide satellite cell RNA-seq analysis are, in fact, satellite
cell autonomous. To do so, we conducted a genome-wide gene
expression analysis of mRNAs in the WT and auf1 KO mouse
skeletal muscle fibers taken from 4- to 6-month-old animals (Fig-
ure S5). MMP9 mRNA was undetectable in both WT and KO
skeletal muscle fibers, indicating that MMP9 expression is solely
satellite cell autonomous and the source of MMP9 overexpres-
sion in auf1 KO mice.
Verification that AUF1 promotes MMP9 mRNA degradation
was obtained in C2C12 myoblast cells, since it is not feasible
to study mRNA decay rates in the animal satellite cell popu-
lation. Silencing of AUF1 by two different small interfering
RNAs (siRNAs) (80%) increased MMP9 mRNA levels by
4-fold (Figure 4C), consistent with that identified in the RNA-
seq data from satellite cells. MMP9 mRNA relative half-life,
determined by the addition of actinomycin D to block transcrip-
tion and qRT-PCR quantitation, was increased from 1 hr in1384 Cell Reports 16, 1379–1390, August 2, 2016vehicle-treated controls to 4.5 hr in C2C12 cells treated with
small interfering (si)AUF1 (80% silenced) (Figure 4D). To
confirm that MMP9 mRNA destabilization is the result of AUF1
action on the ARE repeats in the 30 UTR, the longest contiguous
ARE-rich region (200 bp) was cloned into the 30 UTR of a
luciferase reporter (pzeo-luc). The MMP9-30-Luc reporter or its
control (Empty-30-Luc) was transfected into C2C12 cells with
either non-silencing or siAUF1 treatment. The control mRNA
had a relatively stable half-life of 112min, which was significantly
reduced to 28min by the insertion of theMMP9 30 UTR ARE frag-
ment (MMP9-30-Luc) (Figure S6A). siAUF1 treatment, which
partially silenced AUF1 by 50%–70%, partially rescued MMP9-
30-Luc mRNA stability (81 min). These data confirm that AUF1
promotes the decay of the MMP9 mRNA through the AU-rich
30 UTR (Figure S6A). Further validating these results, cells treated
with siAUF1 showed significantly increased luciferase activity,
validating the role of AUF1 in promoting MMP9 instability
(Figure S6B).
Additionally,MMP9mRNAwas found strongly bound to immu-
noprecipitated AUF1 fromWTC2C12 cells (Figures 4E and S7A).
A suspected AUF1 target mRNA in certain cell types, Integrinb-1
(ITGB1), which was not altered in the satellite cell RNA-seq data,
was used as a control. ITGB1 did not associate with AUF1 in the
C2C12 cells, validating the interaction with MMP9 (Figure 4E).
Moreover, silencing of AUF1 in C2C12 cells strongly increased
secreted MMP9 protein levels (Figures S7B and S7C).
MMP9 Inhibition Rescues Depletion of auf1/ Satellite
Cells following Injury
We determined in live animals, in vivo, whether loss of AUF1-tar-
geted decay of the MMP9 ARE-mRNA is, in large part, respon-
sible for the post-injury muscle regeneration defect, validating
that this phenotype is caused by overexpression from auf1 KO
satellite cells. We used live animal imaging to visualizeMMP9 ac-
tivity in auf1WT and auf1/KO TA skeletal muscle at 24 hr post-
injury in 4-month-old mice. This corresponds to a time point at
which satellite cells are activated in the absence of an immune
infiltrate (Dumont et al., 2015). Mice received an intraperitoneal
(i.p.) injection (in the abdominal cavity) with an optically silent
collagen matrix analog designed for selective MMP9 cleavage
starting 24 hr prior to injury. Once cleaved, the matrix releases
a fluorophore localized to the site of MMP9 activity. MMP9 activ-
ity at the site of repeated i.p. needle injections was expected.
Following BaCl2 TA muscle injury, MMP9 was strongly (>3-fold)
more active in the injured TA skeletal muscle of auf1 KO mice
compared toWTmice (Figure 5A). NoMMP9 activity was evident
in the uninjured right hindlimb control in both theWT and auf1KO
mice (Figure 5A). Surgical excision of the injured TA muscle from
WT and auf1 KO mice, followed by bioluminescence imaging
(Figures 5B and 5C), confirmed that there is an average 3-fold in-
crease in continuous MMP9 activity in auf1 KO mice compared
to WT mice. These data indicate that activated auf1 KO satellite
cells secrete continuous and increased levels of active MMP9
following muscle injury, which is likely exacerbated as the satel-
lite cell population expands.
Therefore, we sought to determine whether the increased
expression and activity of MMP9 are responsible for the auf1
KO injury phenotype observed, particularly, the severe loss of
WT         KO                
Injured TA (I) 
Uninjured TA (UI) 
IP injection (IP) 
 WT             KO
A
B
C
I I IP IP UI UI 
WT KO
0
1 108
2 108
3 108
4 108
Fl
uo
re
sc
en
ce
*
Figure 5. MMP9 Is Significantly More Active in the auf1/ Skeletal
Muscle following Injury
(A) Bioluminescence (in vivo imaging system; IVIS) images of representative
4-month-old mice treated with MMPSense for 48 hr to assess MMP9 activity
24 hr following TA BaCl2 injury of left hindlimb, compared to an uninjured
control (right hindlimb). Three mice per genotype were studied.
(B) IVIS images of representative WT (left) and KO (right) excised TA muscles
treated with MMPSense for 48 hr to assess MMP9 activity 24 hr after injury.
(C) Quantification of MMPSense IVIS images inWT and KO injured TAmuscles
24 hr post-injury. *p < 0.05, unpaired t test.
Error bars represent SD.laminin and depletion of the satellite cell population. Chronically
increased MMP9 activity may promote excessive ECM damage
and subsequent disruption of the satellite cell niche, ultimately
inhibiting satellite cell return to PAX7+ quiescence by interrupting
crucial cell-niche crosstalk. To test this, a MMP9 small-molecule
inhibitor, SB-3CT (Jia et al., 2014; Sassoli et al., 2014), was
administered through i.p. injection to auf1 KO mice in conjunc-
tion with BaCl2-mediated TA injury. SB-3CT blocks MMP9 activ-
ity through an irreversible covalent interaction (Jia et al., 2014;
Sassoli et al., 2014). Mice were treated with 10 mg/kg SB-3CT
daily, starting 24 hr prior to injury, in combination with MMP9-
specific collagen matrix injections (Cai et al., 2015). auf1 KO
mice treated with SB-3CT showed near-complete extinction ofMMP9 activity at the site of i.p. injection and significantly
reduced MMP9 activity in the injured TA muscle (Figure 6A).
Bioluminescence analysis demonstrated a >5-fold reduction in
MMP9 activity in SB-3CT-treated mice post-injury (Figure 6B).
The scale used to quantitate fluorescence is shown in Figure 5.
The reduction in MMP9 activity by SB-3CT treatment in injured
auf1 KOmice resulted in the restoration of muscle wound repair.
Laminin expression was strongly increased, and near-normal
muscle fibers were evident in injured, SB-3CT-treated auf1 KO
animals, consistent with repair of the satellite cell niche (Fig-
ure 6C). Furthermore, the PAX7+ satellite cell population under-
went significant increased expansion 7 days post-injury only in
MMP9-inhibited (SB-3CT-treated) auf1 KO mice (Figure 6C).
Specifically, an4-fold increase was found in the PAX7+ satellite
cell population with SB-3CT treatment following injury (Fig-
ure 6D). These data demonstrate that the severe myopathic pa-
thology of auf1 KOmice following skeletal muscle injury is due to
the loss of AUF1-targeted ARE-mRNA decay, resulting in
increased and constitutive muscle tissue remodeling through
elevated MMP9 activity and subsequent loss of stem cell main-
tenance. These findings further identify the source of late-onset
myopathy observed in aging auf1 KO mice: the accelerated
depletion of the satellite cell population and increased degrada-
tion of laminin due to loss of AUF1-mediated regulation of ARE-
mRNA decay. In both phenotypes, the source of increased
MMP9 is the activated auf1 KO satellite cell, itself causing the
loss of self-renewal, making auf1/ satellite cells act in a self-
sabotaging manner.
DISCUSSION
The targeted decay of ARE-mRNAs by AUBPs has emerged as a
major regulator of many complex physiological pathways and a
source of disease when it goes awry (Moore et al., 2014). AUBPs
have multiple poorly understood roles in orchestrating the
process of myogenesis, whether during development or re-
generation following wound repair. Studies indicate that the
complex and temporally ordered process of muscle regenera-
tion, including the regulation, differentiation, and restoration of
satellite cells in this process, involves a tightly regulated AUBP
network (Dormoy-Raclet et al., 2013; Figueroa et al., 2003; Haus-
burg et al., 2015; Legnini et al., 2014; Panda et al., 2014; Singh
et al., 2014). The individual AUBP molecular activities and coor-
dination of their respective functions are very poorly understood,
particularly in the context of stem-cell-mediated regeneration.
Here, we focused on the role of AUF1 in satellite-cell-mediated
skeletal muscle repair, demonstrating that, in the absence of
functional AUF1, certain ARE-mRNAs in satellite cells are
increased in abundance, disrupting satellite cell differentiation
and self-renewal following wounding. The elevated expression
of active MMP9, encoded by an AUF1-targeted ARE-mRNA,
was found to uncontrollably degrade the surrounding skeletal
muscle ECM, including laminin and the satellite cell niche, gener-
ating a myopathic phenotype similar to that of a variety of late-
onset human myopathic diseases.
The finding that auf1/ mice show accelerated skeletal mus-
cle wasting with aging is likely a result of increased satellite-cell-
secreted MMP9 activity following accumulative minor woundsCell Reports 16, 1379–1390, August 2, 2016 1385
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Figure 6. Inhibition of MMP9 Activity in
auf1/ Mice Restores Maintenance of the
PAX7+ Satellite Cell Population
(A) IVIS images of 4-month-old mice treated with
MMPSense with (right, KO + SB-3CT) or without
(left, KO) SB-3CT for 48 hr to assessMMP9 activity
24 hr after TA muscle BaCl2 injury (left hindlimb)
compared to an uninjured TA muscle (right hin-
dlimb). Three mice per treatment were studied.
(B) Quantification of MMPSense IVIS imaging in
KO and KO + SB-3CT injured TA muscles 24 hr
post-injury. **p < 0.005, unpaired t test.
(C) Immunofluorescence for the expression of
laminin (AF488, green), PAX7 (AF555, red), and
nuclei (DAPI, blue) in skeletal muscle 7 days post-
injury from 4-month-old KO and KO + SB-3CT
mice. TA muscle was injured through BaCl2 in-
jection. TA muscles were frozen in OCT com-
pound, and five images from three sections were
analyzed per mouse (scale bars, 50 mm).
(D) Quantification of PAX7 expression in KO and
KO + SB-3CT mice in 7 days post-injury skeletal
muscle. *p < 0.05, unpaired t test.
Error bars represent SD.over time. Our findings demonstrate that continuous MMP9
activity damages the laminin and ECM structures, disrupting
the quiescent satellite cell niche. This results in a relentless cycle
of destructive degradation and repair established by an MMP9-
driven muscle wounding response, which prematurely activates
and depletes yet more satellite cells. Activated satellite cells then
fuse to existing myofibers, as indicated by the increase in cen-
trally located nuclei in 8-month-old auf1/mice. Consequently,
the loss of functional AUF1, specifically in satellite cells, leads to
a late-onset myopathy, with no phenotype present at a young
age. The chronic and increased expression of MMP9 in the
absence of AUF1-mediated ARE-mRNA decay is, therefore,
clearly a major driver of age-related and post-injury myopathy.
Importantly, the disruption of the satellite cell niche by increased
and unregulatedMMP activity in auf1/mice leads to the partial
depletion of the quiescent PAX7+ satellite cell population, culmi-
nating in the development of a late-onset myopathy observed in
aging and following muscle injury.
Although additional ARE-mRNAs other than MMP9 identified
in the satellite cell RNA-seq analysis likely contribute to the
determination of satellite cell fate and the regulation of skeletal
muscle integrity and regeneration, it is clear that AUF1 regulation
of MMP9 ARE-mRNA decay defines a primary controlling step.
In this regard, the ability to not only restore laminin expres-
sion—and, therefore, muscle regeneration—but also increase
the expansion of auf1/ PAX7+ satellite cells by treatment
with the MMP9 inhibitor SB-3CT underscores the important
function of AUF1-mediated decay of a single ARE-mRNA
(MMP9). This further validates the importance of AUF1-regulated
ARE-mRNA decay in the activation and self-renewal of satellite
cells, mediated through their interaction with the niche. Future
studies will be directed to understanding the role of AUF1 in later1386 Cell Reports 16, 1379–1390, August 2, 2016stages of muscle regeneration, including expansion, differentia-
tion, and fusion of the satellite cell. Accordingly, MEF2C, a late-
stage MRF and AUF1 mRNA target (Panda et al., 2014), was not
identified in our RNA-seq analysis, presumably due to the time
point in regeneration at which auf1/ satellite cells were
selected and sorted for this study.
The chronic and increased expression of MMP9 in the
absence of AUF1-mediated ARE-mRNA decay is, therefore,
clearly a major driver of age-related and post-injury myopathy.
Importantly, the disruption of the satellite cell niche by increased
MMP9 activity in auf1/mice leads to the partial depletion of the
quiescent PAX7+ satellite cell population, culminating in the
development of a late-onset myopathy observed in aging and
following muscle injury.
This work addresses the importance of post-transcriptional
control in the coordinated process of tissue regeneration.
Studies could prove extremely beneficial to further understand-
ing themultiple roles of the different AUBPs in coordinating myo-
genesis and muscle regeneration. Clearly, AUF1 functions at
different temporal points in the process of myogenesis, shown
by work in C2C12 cells (Panda et al., 2014) and here. HuR,
another AUBP that often opposes AUF1 action and stabilizes
ARE-mRNAs (Figueroa et al., 2003), increases in satellite cells
in the very early stages of activation (Legnini et al., 2014), at a
time before the rise in AUF1 expression. HuR promotes the sta-
bility of certain MRFs, such as myogenin and MyoD (Figueroa
et al., 2003). HuR was also recently shown to stabilize the non-
coding RNA linc-MD1, with high expression in the earliest stages
of myogenesis (Legnini et al., 2014), and the mRNA hmgb1
following injury. HMGB1 promotes a motility program involved
as an early activator of the skeletal muscle repair response (Dor-
moy-Raclet et al., 2013). Yet another AUBP, TTP, which is also
an ARE-mRNA-decay mediator, is highly expressed in only
quiescent satellite cells, when AUF1 is not expressed. Further-
more, TTP shows immediate inactivation following injury
when AUF1 expression increases dramatically (Hausburg et al.,
2015). In the quiescent satellite cell, TTP mediates the
rapid decay of theMyoDmRNA, preventing expansion of the sat-
ellite cell population. Previous studies have shown that AUF1
and TTP tend to show mutually exclusive expression or activity
(Moore et al., 2014), consistent with these findings and with
our data that AUF1 is only expressed following satellite cell
activation.
Reported data led to the possibility that the loss or mutation of
AUF1 was related to the development of LGMD, a late-onset hu-
manmyopathy. Multiple family cohorts with LGMD type 1G have
a mutation in the 4q21 locus, which contains the auf1 gene, and
one family was shown to have a mutation in HNRNPDL, a poorly
described AUF1 homolog (Starling et al., 2004; Vieira et al.,
2014). The age of onset for LGMD type 1G ranged from 30 to
47 years, with no childhood history of myopathy (Starling et al.,
2004; Vieira et al., 2014). As clinically described, LGMD shows
a similar relative age of onset and histological representation
as identified in the auf1/ mouse.
In summary, our work identifies a myopathy of true satellite-
cell origin in an animal model and places the AUBPmRNA-decay
protein AUF1 as a key regulator of adult stem cell fate. These
findings have important clinical implications. While healthy
skeletal muscle can develop in the absence of functional
AUF1, the satellite-cell population is clearly altered and, once
activated, is quickly depleted. Activated auf1/ satellite cells
secrete elevated levels of MMP9 that continuously break down
the ECM and niche, causing premature satellite cell activation,
satellite cell depletion, and subsequent development of myop-
athy with age. Consequently, a combination of MMP9 inhibition
and potential AUF1-mediated satellite cell therapy may have a
role in regenerative medicine for chronic and acute adult
myopathies.
EXPERIMENTAL PROCEDURES
Animal Studies
All animal studies were approved by the New York University (NYU) School of
Medicine Institutional Animal Care and Use Committee protocol #140414-01
and conducted in accordance with IACUC guidelines.
DEXA
The Lunar Pixi DEXA was used to record lean tissue muscle mass as per man-
ufacturer’s recommendations. Male and female mice from 3 to 12 months of
age were weighed for total body mass and scanned for lean body mass.
Mice were divided into the following age groups: 3–5, 6–8, and 9–12 months.
A ratio of lean body mass to total body mass was used for analysis. Five mice
per genotype per age group were analyzed in triplicate, and then means and
SDs were calculated. Data were analyzed with an unpaired t test. (Harada,
2013; Marinangeli and Kassis, 2013).
Cage Flip
Male and female mice were placed on a grid for 30 s to acclimate before being
inverted for up to 60 s at a height of 3 feet. The time until mice let go of the grid
was recorded. Mice were divided into the following age groups: 3–5, 6–8, and
9–12 months. Five mice per genotype per age group were tested in triplicate,
and then means and SDs were calculated. Data were analyzed with an un-
paired t test.Strength Grip
Male and female mice 6 months of age were tested as per manufacturer’s rec-
ommendations (Bioseb). In brief, mice were handled by their tails and allowed
to grab a grid attached to a force monitor with their upper limbs. Mice were
pulled off the grid by their tail, and a measurement of upper limb strength
was recorded. Five mice per genotype were tested in triplicate, and then
means and SDs were calculated. Data were analyzed with an unpaired t test
(Ke et al., 2015; van Norren et al., 2015).
Immunofluorescence
Male and female mice 4–8 months of age (designated by experiment) had their
TA muscles removed and frozen in OCT (optimum cutting temperature) com-
pound (Tissue-Tek). Samples were post-fixed in 4% paraformaldehyde and
blocked in 3%BSA in Tris-buffered saline (TBS). Primary antibodieswere incu-
bated at 4C overnight. Alexa Fluor donkey 488, 555, and 647 secondary an-
tibodies were used at 1:500 and incubated for 1 hr at room temperature. Slides
were sealed with Vectashield with DAPI. The following antibody dilutions were
used: rat antibody to laminin (Sigma, L0663, 1:250), mouse antibody to PAX7
(Developmental Studies Hybridoma Bank [DSHB], 1:1,000; PAX7 was depos-
ited to the DSHB by Atsushi Kawakami), goat antibody to HNRNPD (Santa
Cruz Biotechnology, SC-22368, 1:250), and rabbit antibody to MyoD (Santa
Cruz Biotechnology, SC-760, 1:1,000).
Microscopy, Image Processing, and Analysis
Images were acquired using a Zeiss LSM 700 confocal microscope, primarily
with the 203 lens. Images were processed and scored using ImageJ64. If
needed, color balancewas adjusted linearly for the entire image and all images
in experimental sets.
BaCl2 Hindlimb Injury
Male and female mice at 4 months of age were injected with 50 ml filtered 1.2%
BaCl2 in saline directly in the left TA muscle. The right TA muscle remained un-
injured as a control. Mice were monitored and sacrificed by protocol at 7 and
15 days post-injection. Injured and uninjured TA muscles were surgically
removed and frozen in OCT compound (Tissue-Tek) post-sacrifice. Three
mice per genotype per time point were studied (Bernet et al., 2014; Cornelison
et al., 2001).
Myofiber Preparation
Myofibers were harvested from WT and KO mice at 4 months of age. In brief,
muscles beneath the TAmuscle, including the extensor digitorum longus (EDL)
and soleus, were dissected from the hindlimb and digested in 1.5 U/ml type 1
collagenase (Worthington) for 1.5 hr in a 37C water bath. Myofibers were
cultured for 72 hr in F12 media (Corning) supplemented with 15% horse serum
(GIBCO), 1% penicillin-streptomycin (Life Technologies), and 2.5 mg/ml fibro-
blast growth factor (FGF; Sigma) at 37C in a 5% CO2 tissue culture incubator
(Tanaka et al., 2009).
C2C12 Cell Culture
C2C12 cells were maintained in DMEM (Corning), 20% fetal bovine serum
(FBS; GIBCO), and 1%penicillin-streptomycin (Life Technologies). To differen-
tiate cells, media were switched to DMEM (Corning), 2% horse serum
(GIBCO), and 1% penicillin-streptomycin (Life Technologies) (Panda et al.,
2014).
FACS
Whole hindlimb skeletal muscle from male and female mice ages 4–6 months
old was digested in type 1 collagenase (Worthington) and sorted for the
Sdc4+cd45cd31Sca1 population using a Beckman Coulter MoFlo XDP
cell sorter. Lineage markers were excited by a Sapphire 488-nm laser
(Coherent) and collected via a 530/40 band-pass filter. Sdc4 (conjugated to
Qdot 800 using the SiteClick antibody conjugation kit) was also excited by a
Sapphire 488-nm laser (Coherent) and collected via a 740 long-pass filter.
DAPI was used to select for live/intact cells and was excited by a JDSU Xcyte
355-nm laser and collected via a 450/65 band-pass filter. Events were run
through a 70-mm cyto-nozzle at approximately 10,000 events per second.Cell Reports 16, 1379–1390, August 2, 2016 1387
RNA-Seq and Analysis
RNA was extracted from FACS-sorted satellite cells using TRIzol (Thermo
Fisher Scientific) and purified using the RNeasy Mini Kit (QIAGEN) as per man-
ufacturer’s instructions. Whole hindlimb skeletal muscle of male and female
mice ages 4–6 months old was processed. Three mice were analyzed per ge-
notype. RNA-seq was completed through the NYU School of Medicine
Genome Technology Core, using the Illumina Hi-Seq 2500 Single Read, and
analyzed through the NYU-CTSI (Clinical and Translational Science Institute)
Bioinformatics Core.
Affymetrix Genome-wide mRNA Analysis
RNA was extracted from whole hindlimb skeletal muscle with TRIzol (Thermo
Fisher Scientific) and purified using the RNeasy Mini Kit (QIAGEN) as per man-
ufacturer’s instructions. Whole hindlimb skeletal muscle of male and female
mice 4–6 months old was processed. Five mice were analyzed per genotype.
Affymetrix GeneChip Mouse Genome 430 2.0 Array chips were used. Affyme-
trix chips were processed by the NYU School of Medicine Genome Technol-
ogy Core and analyzed through the NYU School of Medicine Bioinformatics
Core.
In Vitro AUF1 Silencing
AUF1 was transiently silenced in vitro using 50 mM Ambion siRNA (s62815,
s201078) and Life Technology Lipofectamine 2000 for 48 hr. For extended
studies, cells were treated with siRNA every 72 hr as needed.
MMP9 ELISA
Tissue culture media were collected and tested using the Molecular Probes
EnzChek Gelatinase/Collagenase Assay Kit, as per manufacturer’s instruc-
tions. Experiments were analyzed in triplicate, and then means and SDs
were calculated. Data were analyzed by unpaired t test.
In Vivo MMP9 Activity
WT and KOmale and female mice 4 months of age were given an i.p. injection
with PerkinElmer MMPSense 750 solution 24 hr prior to injury and the time of
BaCl2 injection, 24 hr prior to imaging. Animals were imaged using IVIS L-III
through the NYU School of Medicine Small Animal Imaging Core. Three
mice per genotype were analyzed, and then means and SDs were calculated.
Data were analyzed with an unpaired t test.
SB-3CT Treatment
KO male and female mice 4 months of age were given an i.p. injection with
25 mg/kg SB-3CT (Sigma-Aldrich) every 24 hr, starting 24 hr prior to BaCl2
injury with MMPSense injection. Three mice per treatment were analyzed,
and then means and SDs were calculated. Data were analyzed with an un-
paired t test.
Statistical Analysis
Unpaired t test or two-way ANOVA was used when applicable to determine
significance. Data were analyzed using Prism 6.0f. Significant values are
considered as p < 0.05, p < 0.005, and p < 0.0005.
ACCESSION NUMBERS
The accession number for the gene expression data, including all RNA-seq
data, reported in this paper is GEO: GSE83555.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.06.095.
AUTHOR CONTRIBUTIONS
D.M.C., R.J.S., B.B.O., and A.B.C. designed the studies; D.M.C. carried out
the majority of the studies; A.B.C. and T.L.A. participated in carrying out hin-1388 Cell Reports 16, 1379–1390, August 2, 2016dlimb injury studies and satellite cell FACS; L.C.L. assisted in all mouse main-
tenance, phenotype analysis, and injury with SB-3CT rescue experiments;
J.W. conducted bioinformatics analysis from RNA-seq and Affymetrix plat-
forms; R.J.S. directed the project; D.M.C. and R.J.S. wrote the manuscript;
and B.B.O. and A.B.C. participated in manuscript revision.ACKNOWLEDGMENTS
We thank Dr. Bruce Cronstein (NYU) for use of the DEXA. Technical assistance
was provided by the NYU-CTSI Bioinformatics Core, Histopathology Core, Mi-
croscopy Core, Rodent Behavior Core, and Small Animal Imaging Core, sup-
ported in part by grant UL1 TR00038 from NCATS. This work was supported
by NIH grants GM085693 and R24OD018339 to R.J.S., NIH T32 13-A0-S1-
090476 to D.M.C., and AR049446 to B.B.O., who is also supported as a Senior
Scholar in Aging Research by the Ellison Medical Foundation.
Received: March 3, 2016
Revised: May 26, 2016
Accepted: June 29, 2016
Published: July 21, 2016
REFERENCES
Bernet, J.D., Doles, J.D., Hall, J.K., Kelly Tanaka, K., Carter, T.A., and Olwin,
B.B. (2014). p38 MAPK signaling underlies a cell-autonomous loss of stem
cell self-renewal in skeletal muscle of aged mice. Nat. Med. 20, 265–271.
Brack, A.S. (2014). Pax7 is back. Skelet. Muscle 4, 24.
Cai, H., Mu, Z., Jiang, Z., Wang, Y., Yang, G.Y., and Zhang, Z. (2015). Hypoxia-
controlled matrix metalloproteinase-9 hyperexpression promotes behavioral
recovery after ischemia. Neurosci. Bull. 31, 550–560.
Carlson, M.E., and Conboy, I.M. (2007). Loss of stem cell regenerative capac-
ity within aged niches. Aging Cell 6, 371–382.
Cheadle, C., Fan, J., Cho-Chung, Y.S., Werner, T., Ray, J., Do, L., Gorospe,
M., and Becker, K.G. (2005). Control of gene expression during T cell activa-
tion: alternate regulation of mRNA transcription and mRNA stability. BMC Ge-
nomics 6, 75.
Collins, C.A., Olsen, I., Zammit, P.S., Heslop, L., Petrie, A., Partridge, T.A., and
Morgan, J.E. (2005). Stem cell function, self-renewal, and behavioral heteroge-
neity of cells from the adult muscle satellite cell niche. Cell 122, 289–301.
Cornelison, D.D., andWold, B.J. (1997). Single-cell analysis of regulatory gene
expression in quiescent and activated mouse skeletal muscle satellite cells.
Dev. Biol. 191, 270–283.
Cornelison, D.D., Filla, M.S., Stanley, H.M., Rapraeger, A.C., and Olwin, B.B.
(2001). Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite
cells and are implicated in satellite cell maintenance and muscle regeneration.
Dev. Biol. 239, 79–94.
Dormoy-Raclet, V., Cammas, A., Celona, B., Lian, X.J., van der Giessen, K.,
Zivojnovic, M., Brunelli, S., Riuzzi, F., Sorci, G., Wilhelm, B.T., et al. (2013).
HuR and miR-1192 regulate myogenesis by modulating the translation of
HMGB1 mRNA. Nat. Commun. 4, 2388.
Dumont, N.A., Wang, Y.X., and Rudnicki, M.A. (2015). Intrinsic and extrinsic
mechanisms regulating satellite cell function. Development 142, 1572–1581.
Figueroa, A., Cuadrado, A., Fan, J., Atasoy, U., Muscat, G.E., Mun˜oz-Can-
oves, P., Gorospe, M., and Mun˜oz, A. (2003). Role of HuR in skeletal myogen-
esis through coordinate regulation of muscle differentiation genes. Mol. Cell.
Biol. 23, 4991–5004.
Garneau, N.L.,Wilusz, J., andWilusz, C.J. (2007). The highways and byways of
mRNA decay. Nat. Rev. Mol. Cell Biol. 8, 113–126.
Gopinath, S.D., and Rando, T.A. (2008). Stem cell review series: aging of the
skeletal muscle stem cell niche. Aging Cell 7, 590–598.
Grataco´s, F.M., and Brewer, G. (2010). The role of AUF1 in regulated mRNA
decay. Wiley Interdiscip. Rev. RNA 1, 457–473.
Gruber, A.R., Fallmann, J., Kratochvill, F., Kovarik, P., and Hofacker, I.L.
(2011). AREsite: a database for the comprehensive investigation of AU-rich el-
ements. Nucleic Acids Res. 39, D66–D69.
Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A.Y., and
Lipton, S.A. (2005). A highly specific inhibitor of matrix metalloproteinase-9
rescues laminin from proteolysis and neurons from apoptosis in transient focal
cerebral ischemia. J. Neurosci. 25, 6401–6408.
G€unther, S., Kim, J., Kostin, S., Lepper, C., Fan, C.M., and Braun, T. (2013).
Myf5-positive satellite cells contribute to Pax7-dependent long-term mainte-
nance of adult muscle stem cells. Cell Stem Cell 13, 590–601.
Han, X., Yang, Q., Lin, L., Xu, C., Zheng, C., Chen, X., Han, Y., Li, M., Cao, W.,
Cao, K., et al. (2014). Interleukin-17 enhances immunosuppression by mesen-
chymal stem cells. Cell Death Differ. 21, 1758–1768.
Harada, A. (2013). [Evaluation of musclemass using Dual energy X-ray absorp-
tiometry]. Clin. Calcium 23, 361–364.
Hausburg, M.A., Doles, J.D., Clement, S.L., Cadwallader, A.B., Hall, M.N.,
Blackshear, P.J., Lykke-Andersen, J., and Olwin, B.B. (2015). Post-transcrip-
tional regulation of satellite cell quiescence by TTP-mediated mRNA decay.
eLife 4, e03390.
He, C., and Schneider, R. (2006). 14-3-3sigma is a p37 AUF1-binding protein
that facilitates AUF1 transport and AU-rich mRNA decay. EMBO J. 25, 3823–
3831.
Hindi, S.M., Shin, J., Ogura, Y., Li, H., and Kumar, A. (2013). Matrix metallopro-
teinase-9 inhibition improves proliferation and engraftment of myogenic cells
in dystrophic muscle of mdx mice. PLoS ONE 8, e72121.
Ho, T.C., Chiang, Y.P., Chuang, C.K., Chen, S.L., Hsieh, J.W., Lan, Y.W., and
Tsao, Y.P. (2015). PEDF-derived peptide promotes skeletal muscle regenera-
tion through itsmitogenic effect onmuscle progenitor cells. Am. J. Physiol. Cell
Physiol. 309, C159–C168.
Jia, F., Yin, Y.H., Gao, G.Y., Wang, Y., Cen, L., and Jiang, J.Y. (2014). MMP-9
inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss
after traumatic brain injury in rat. J. Neurotrauma 31, 1225–1234.
Ke, Y.D., van Hummel, A., Stevens, C.H., Gladbach, A., Ippati, S., Bi, M., Lee,
W.S., Kr€uger, S., van der Hoven, J., Volkerling, A., et al. (2015). Short-term
suppression of A315T mutant human TDP-43 expression improves functional
deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Acta Neuropathol. 130, 661–678.
Kim,M.Y., Hur, J., and Jeong, S. (2009). Emerging roles of RNA and RNA-bind-
ing protein network in cancer cells. BMB Rep. 42, 125–130.
Kuang, S., Kuroda, K., Le Grand, F., and Rudnicki, M.A. (2007). Asymmetric
self-renewal and commitment of satellite stem cells in muscle. Cell 129,
999–1010.
Kudryashova, E., Kramerova, I., and Spencer, M.J. (2012). Satellite cell senes-
cence underlies myopathy in a mouse model of limb-girdle muscular dystro-
phy 2H. J. Clin. Invest. 122, 1764–1776.
Legnini, I., Morlando, M., Mangiavacchi, A., Fatica, A., and Bozzoni, I. (2014). A
feedforward regulatory loop between HuR and the long noncoding RNA linc-
MD1 controls early phases of myogenesis. Mol. Cell 53, 506–514.
Lepper, C., Conway, S.J., and Fan, C.M. (2009). Adult satellite cells and em-
bryonic muscle progenitors have distinct genetic requirements. Nature 460,
627–631.
Li, H., Mittal, A., Makonchuk, D.Y., Bhatnagar, S., and Kumar, A. (2009). Matrix
metalloproteinase-9 inhibition ameliorates pathogenesis and improves skel-
etal muscle regeneration in muscular dystrophy. Hum. Mol. Genet. 18,
2584–2598.
Lipton, B.H., and Schultz, E. (1979). Developmental fate of skeletal muscle sat-
ellite cells. Science 205, 1292–1294.
Liu, W., Rosenberg, G.A., and Liu, K.J. (2006). AUF-1 mediates inhibition by ni-
tric oxide of lipopolysaccharide-induced matrix metalloproteinase-9 expres-
sion in cultured astrocytes. J. Neurosci. Res. 84, 360–369.
Lu, J.Y., and Schneider, R.J. (2004). Tissue distribution of AU-richmRNA-bind-
ing proteins involved in regulation of mRNA decay. J. Biol. Chem. 279, 12974–
12979.Lu, J.Y., Sadri, N., and Schneider, R.J. (2006). Endotoxic shock in AUF1
knockout mice mediated by failure to degrade proinflammatory cytokine
mRNAs. Genes Dev. 20, 3174–3184.
Marinangeli, C.P., and Kassis, A.N. (2013). Use of dual X-ray absorptiometry to
measure body mass during short- to medium-term trials of nutrition and exer-
cise interventions. Nutr. Rev. 71, 332–342.
Montarras, D., Morgan, J., Collins, C., Relaix, F., Zaffran, S., Cumano, A.,
Partridge, T., and Buckingham, M. (2005). Direct isolation of satellite cells for
skeletal muscle regeneration. Science 309, 2064–2067.
Moore, A.E., Chenette, D.M., Larkin, L.C., and Schneider, R.J. (2014). Physio-
logical networks and disease functions of RNA-binding protein AUF1.Wiley In-
terdiscip. Rev. RNA 5, 549–564.
Murase, S., andMcKay, R.D. (2012). Matrix metalloproteinase-9 regulates sur-
vival of neurons in newborn hippocampus. J. Biol. Chem. 287, 12184–12194.
Panda, A.C., Abdelmohsen, K., Yoon, J.H., Martindale, J.L., Yang, X., Curtis,
J., Mercken, E.M., Chenette, D.M., Zhang, Y., Schneider, R.J., et al. (2014).
RNA-binding protein AUF1 promotes myogenesis by regulating MEF2C
expression levels. Mol. Cell. Biol. 34, 3106–3119.
Pont, A.R., Sadri, N., Hsiao, S.J., Smith, S., and Schneider, R.J. (2012). mRNA
decay factor AUF1 maintains normal aging, telomere maintenance, and sup-
pression of senescence by activation of telomerase transcription. Mol. Cell
47, 5–15.
Sarkar, B., Lu, J.Y., and Schneider, R.J. (2003a). Nuclear import and export
functions in the different isoforms of the AUF1/heterogeneous nuclear ribonu-
cleoprotein protein family. J. Biol. Chem. 278, 20700–20707.
Sarkar, B., Xi, Q., He, C., and Schneider, R.J. (2003b). Selective degradation of
AU-richmRNAs promoted by the p37 AUF1 protein isoform. Mol. Cell. Biol. 23,
6685–6693.
Sarkar, S., Sinsimer, K.S., Foster, R.L., Brewer, G., and Pestka, S. (2008).
AUF1 isoform-specific regulation of anti-inflammatory IL10 expression in
monocytes. J. Interferon Cytokine Res. 28, 679–691.
Sarkar, S., Han, J., Sinsimer, K.S., Liao, B., Foster, R.L., Brewer, G., and
Pestka, S. (2011). RNA-binding protein AUF1 regulates lipopolysaccharide-
induced IL10 expression by activating IkappaB kinase complex in monocytes.
Mol. Cell. Biol. 31, 602–615.
Sassoli, C., Nosi, D., Tani, A., Chellini, F., Mazzanti, B., Quercioli, F., Zecchi-
Orlandini, S., and Formigli, L. (2014). Defining the role of mesenchymal stromal
cells on the regulation of matrix metalloproteinases in skeletal muscle cells.
Exp. Cell Res. 323, 297–313.
Seale, P., and Rudnicki, M.A. (2000). A new look at the origin, function, and
‘‘stem-cell’’ status of muscle satellite cells. Dev. Biol. 218, 115–124.
Shefer, G., Van de Mark, D.P., Richardson, J.B., and Yablonka-Reuveni, Z.
(2006). Satellite-cell pool size does matter: defining the myogenic potency of
aging skeletal muscle. Dev. Biol. 294, 50–66.
Shiba, N., Miyazaki, D., Yoshizawa, T., Fukushima, K., Shiba, Y., Inaba, Y., Im-
amura, M., Takeda, S., Koike, K., and Nakamura, A. (2015). Differential roles of
MMP-9 in early and late stages of dystrophic muscles in a mouse model of
Duchenne muscular dystrophy. Biochim. Biophys. Acta 1852 (10 Pt A),
2170–2182.
Silva, K.A., Dong, J., Dong, Y., Dong, Y., Schor, N., Tweardy, D.J., Zhang, L.,
and Mitch, W.E. (2015). Inhibition of Stat3 activation suppresses caspase-3
and the ubiquitin-proteasome system, leading to preservation of muscle
mass in cancer cachexia. J. Biol. Chem. 290, 11177–11187.
Singh, R.K., Xia, Z., Bland, C.S., Kalsotra, A., Scavuzzo, M.A., Curk, T., Ule, J.,
Li, W., and Cooper, T.A. (2014). Rbfox2-coordinated alternative splicing of
Mef2d and Rock2 controls myoblast fusion during myogenesis. Mol. Cell 55,
592–603.
Sousa-Victor, P., Gutarra, S., Garcı´a-Prat, L., Rodriguez-Ubreva, J., Ortet, L.,
Ruiz-Bonilla, V., Jardı´, M., Ballestar, E., Gonza´lez, S., Serrano, A.L., et al.
(2014). Geriatric muscle stem cells switch reversible quiescence into senes-
cence. Nature 506, 316–321.
Starling, A., Kok, F., Passos-Bueno, M.R., Vainzof, M., and Zatz, M. (2004). A
new form of autosomal dominant limb-girdle muscular dystrophy (LGMD1G)Cell Reports 16, 1379–1390, August 2, 2016 1389
with progressive fingers and toes flexion limitation maps to chromosome
4p21. Eur. J. Hum. Genet. 12, 1033–1040.
Suzuki, M., Iijima, M., Nishimura, A., Tomozoe, Y., Kamei, D., and Yamada, M.
(2005). Two separate regions essential for nuclear import of the hnRNP D nu-
cleocytoplasmic shuttling sequence. FEBS J. 272, 3975–3987.
Tanaka, K.K., Hall, J.K., Troy, A.A., Cornelison, D.D., Majka, S.M., and Olwin,
B.B. (2009). Syndecan-4-expressing muscle progenitor cells in the SP engraft
as satellite cells during muscle regeneration. Cell Stem Cell 4, 217–225.
van Norren, K., Rusli, F., van Dijk, M., Lute, C., Nagel, J., Dijk, F.J., Dwarkasing,
J., Boekschoten, M.V., Luiking, Y., Witkamp, R.F., et al. (2015). Behavioural
changes are a major contributing factor in the reduction of sarcopenia in
caloric-restricted ageing mice. J. Cachexia Sarcopenia Muscle 6, 253–268.
Vieira, N.M., Naslavsky, M.S., Licinio, L., Kok, F., Schlesinger, D., Vainzof, M.,
Sanchez, N., Kitajima, J.P., Gal, L., Cavac¸ana, N., et al. (2014). A defect in the
RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G
(LGMD1G). Hum. Mol. Genet. 23, 4103–4110.
von Roretz, C., Di Marco, S., Mazroui, R., and Gallouzi, I.E. (2011). Turnover of
AU-rich-containing mRNAs during stress: a matter of survival. Wiley Interdis-
cip. Rev. RNA 2, 336–347.1390 Cell Reports 16, 1379–1390, August 2, 2016Wagner, B.J., DeMaria, C.T., Sun, Y., Wilson, G.M., and Brewer, G. (1998).
Structure and genomic organization of the human AUF1 gene: alternative
pre-mRNA splicing generates four protein isoforms. Genomics 48, 195–202.
Webster, M.T., Manor, U., Lippincott-Schwartz, J., and Fan, C.M. (2016). Intra-
vital imaging reveals ghost fibers as architectural units guiding myogenic pro-
genitors during regeneration. Cell Stem Cell 18, 243–252.
Wicklund, M.P., and Kissel, J.T. (2014). The limb-girdle muscular dystrophies.
Neurol. Clin. 32, 729–749, ix.
Yoon, J.H., Jo, M.H., White, E.J., De, S., Hafner, M., Zucconi, B.E., Abdelmoh-
sen, K., Martindale, J.L., Yang, X., Wood, W.H., 3rd., et al. (2015). AUF1 pro-
motes let-7b loading on Argonaute 2. Genes Dev. 29, 1599–1604.
Zammit, P.S., Golding, J.P., Nagata, Y., Hudon, V., Partridge, T.A., and Beau-
champ, J.R. (2004). Muscle satellite cells adopt divergent fates: a mechanism
for self-renewal? J. Cell Biol. 166, 347–357.
Zucconi, B.E., Ballin, J.D., Brewer, B.Y., Ross, C.R., Huang, J., Toth, E.A., and
Wilson, G.M. (2010). Alternatively expressed domains of AU-rich element
RNA-binding protein 1 (AUF1) regulate RNA-binding affinity, RNA-induced
protein oligomerization, and the local conformation of bound RNA ligands.
J. Biol. Chem. 285, 39127–39139.
